MCP1 Directs Trafficking of Hematopoietic Stem Cell-derived Fibroblast Precursors in Solid Tumor

Overview

Journal Am J Pathol

Publisher Elsevier

Specialty Pathology

Date 2010 Feb 20

PMID 20167869

Citations 22

Authors

Romeo S Abangan Jr

Christopher R Williams

Meenal Mehrotra

James D Duncan

Amanda C LaRue

Affiliations

Soon will be listed here.

Abstract

Our previous studies have demonstrated that hematopoietic stem cells (HSCs) are a novel source of carcinoma-associated fibroblasts. However, the mechanisms regulating recruitment and homing of HSC-derived carcinoma-associated fibroblasts or their precursors to the tumor microenvironment are unknown. Herein, we demonstrate using a single cell transplantation model that circulating fibroblast precursors (CFPs) are of HSC origin. This population increased with tumor burden in vivo and functional in vitro studies showed that CFPs preferentially migrated and differentiated into fibroblasts in response to tumor, suggesting that HSC-derived CFPs serve as an intermediate between the bone marrow and tumor. Based on this chemotactic ability and our demonstration of a monocyte lineage origin for CFPs, we investigated the role of monocyte chemoattractant protein (MCP1) in mediating CFP recruitment/homing. Blocking tumor-produced MCP1 inhibited in vitro migration of CFPs in response to multiple tumor types, indicating broad biological significance for this CFP/chemokine interaction. In vivo, CCR2-expressing CFPs increased in circulation during the period of active tumor growth and stromal development. Inhibition of MCP1 during tumor development resulted in decreased tumor volume in tumor-bearing mice. Together these findings confirm an HSC origin for CFPs, demonstrate a role for MCP1 in regulating their contribution to the tumor microenvironment, and suggest a potential therapeutic target for limiting tumor growth.

Citing Articles

Cancer-Associated Fibroblast Heterogeneity in Malignancy with Focus on Oral Squamous Cell Carcinoma.

Arebro J, Lee C, Bennewith K, Garnis C Int J Mol Sci. 2024; 25(2).

PMID: 38279300 PMC: 10816981. DOI: 10.3390/ijms25021300.

Identification and characterization of FGFR2 hematopoietic stem cell-derived fibrocytes as precursors of cancer-associated fibroblasts induced by esophageal squamous cell carcinoma.

Qiu H, Zhang X, Qi J, Zhang J, Tong Y, Li L J Exp Clin Cancer Res. 2022; 41(1):240.

PMID: 35941662 PMC: 9358838. DOI: 10.1186/s13046-022-02435-w.

Fight the Cancer, Hit the CAF!.

Papait A, Romoli J, Stefani F, Chiodelli P, Montresor M, Agoni L Cancers (Basel). 2022; 14(15).

PMID: 35892828 PMC: 9330284. DOI: 10.3390/cancers14153570.

Irbesartan, an angiotensin II type 1 receptor blocker, inhibits colitis-associated tumourigenesis by blocking the MCP-1/CCR2 pathway.

Hachiya K, Masuya M, Kuroda N, Yoneda M, Tsuboi J, Nagaharu K Sci Rep. 2021; 11(1):19943.

PMID: 34620946 PMC: 8497524. DOI: 10.1038/s41598-021-99412-8.

Cancer-associated fibroblasts: overview, progress, challenges, and directions.

Ping Q, Yan R, Cheng X, Wang W, Zhong Y, Hou Z Cancer Gene Ther. 2021; 28(9):984-999.

PMID: 33712707 DOI: 10.1038/s41417-021-00318-4.

References

Ebihara Y, Masuya M, LaRue A, Fleming P, Visconti R, Minamiguchi H . Hematopoietic origins of fibroblasts: II. In vitro studies of fibroblasts, CFU-F, and fibrocytes. Exp Hematol. 2006; 34(2):219-29. DOI: 10.1016/j.exphem.2005.10.008. View

Tomayko M, Reynolds C . Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol. 1989; 24(3):148-54. DOI: 10.1007/BF00300234. View

Osawa M, Hanada K, Hamada H, Nakauchi H . Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science. 1996; 273(5272):242-5. DOI: 10.1126/science.273.5272.242. View

Ikebuchi K, Clark S, Ihle J, Souza L, Ogawa M . Granulocyte colony-stimulating factor enhances interleukin 3-dependent proliferation of multipotential hemopoietic progenitors. Proc Natl Acad Sci U S A. 1988; 85(10):3445-9. PMC: 280228. DOI: 10.1073/pnas.85.10.3445. View

Kurt R, Baher A, Wisner K, Tackitt S, Urba W . Chemokine receptor desensitization in tumor-bearing mice. Cell Immunol. 2001; 207(2):81-8. DOI: 10.1006/cimm.2000.1754. View

Roorda B, Ter Elst A, Kamps W, de Bont E . Bone marrow-derived cells and tumor growth: contribution of bone marrow-derived cells to tumor micro-environments with special focus on mesenchymal stem cells. Crit Rev Oncol Hematol. 2008; 69(3):187-98. DOI: 10.1016/j.critrevonc.2008.06.004. View

de Wever O, Mareel M . Role of tissue stroma in cancer cell invasion. J Pathol. 2003; 200(4):429-47. DOI: 10.1002/path.1398. View

Haudek S, Trial J, Xia Y, Gupta D, Pilling D, Entman M . Fc receptor engagement mediates differentiation of cardiac fibroblast precursor cells. Proc Natl Acad Sci U S A. 2008; 105(29):10179-84. PMC: 2465805. DOI: 10.1073/pnas.0804910105. View

Johnstone B, Hering T, Caplan A, Goldberg V, Yoo J . In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res. 1998; 238(1):265-72. DOI: 10.1006/excr.1997.3858. View

10.

Ryden M, Dicker A, Gotherstrom C, Astrom G, Tammik C, Arner P . Functional characterization of human mesenchymal stem cell-derived adipocytes. Biochem Biophys Res Commun. 2003; 311(2):391-7. DOI: 10.1016/j.bbrc.2003.10.010. View

11.

Shirai K, Sera Y, Bulkeley W, Mehrotra M, Moussa O, LaRue A . Hematopoietic stem cell origin of human fibroblasts: cell culture studies of female recipients of gender-mismatched stem cell transplantation and patients with chronic myelogenous leukemia. Exp Hematol. 2009; 37(12):1464-71. PMC: 2802494. DOI: 10.1016/j.exphem.2009.09.008. View

12.

Reyes M, Dudek A, Jahagirdar B, Koodie L, Marker P, Verfaillie C . Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest. 2002; 109(3):337-46. PMC: 150857. DOI: 10.1172/JCI14327. View

13.

Nesbit M, Schaider H, MILLER T, Herlyn M . Low-level monocyte chemoattractant protein-1 stimulation of monocytes leads to tumor formation in nontumorigenic melanoma cells. J Immunol. 2001; 166(11):6483-90. DOI: 10.4049/jimmunol.166.11.6483. View

14.

Phillips R, Burdick M, Hong K, Lutz M, Murray L, Xue Y . Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest. 2004; 114(3):438-46. PMC: 484979. DOI: 10.1172/JCI20997. View

15.

Radisky D, Kenny P, Bissell M . Fibrosis and cancer: do myofibroblasts come also from epithelial cells via EMT?. J Cell Biochem. 2007; 101(4):830-9. PMC: 2838476. DOI: 10.1002/jcb.21186. View

16.

Shao D, Suresh R, Vakil V, Gomer R, Pilling D . Pivotal Advance: Th-1 cytokines inhibit, and Th-2 cytokines promote fibrocyte differentiation. J Leukoc Biol. 2008; 83(6):1323-33. PMC: 2659591. DOI: 10.1189/jlb.1107782. View

17.

Goodell M, Rosenzweig M, Kim H, Marks D, Demaria M, Paradis G . Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat Med. 1997; 3(12):1337-45. DOI: 10.1038/nm1297-1337. View

18.

Mishra P, Mishra P, Humeniuk R, Medina D, Alexe G, Mesirov J . Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res. 2008; 68(11):4331-9. PMC: 2725025. DOI: 10.1158/0008-5472.CAN-08-0943. View

19.

Luria E, Panasyuk A, Friedenstein A . Fibroblast colony formation from monolayer cultures of blood cells. Transfusion. 1971; 11(6):345-9. DOI: 10.1111/j.1537-2995.1971.tb04426.x. View

20.

Ogawa M, LaRue A, Drake C . Hematopoietic origin of fibroblasts/myofibroblasts: Its pathophysiologic implications. Blood. 2006; 108(9):2893-6. DOI: 10.1182/blood-2006-04-016600. View